Biotechnology Annual Review ( Volume 13 )

Publication series :Volume 13

Author: El-Gewely   M. Raafat  

Publisher: Elsevier Science‎

Publication year: 2007

E-ISBN: 9780080553689

P-ISBN(Paperback): 9780444530325

P-ISBN(Hardback):  9780444530325

Subject: Q-33 Biological experiments with biological technology

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Biotechnology is a diverse, complex and rapidly evolving field. Students and experienced researchers alike face the challenges of staying on top of developments in their field of specialty and maintaining a broader overview of the field as a whole. Volumes containing competent reviews on a diverse range of topics in the field fulfill the dual role of broadening and updating biotechnologists’ knowledge. The current volume is an excellent example of such a book. The topics covered range from classical issues in biotechnology - such as, recent advances in all-protein chromophore technology- to topics that are focused on sequencing and recombinant vaccines. The information presented in this book will therefore will be of great value to both experienced biotechnologists and biotechnologists in training.

* Includes over 200 figures with more than 60 tables
* Discusses valuable information on pharming & transgenic plants
* Provides detailed information on the production of plasmid DNA for pharmaceutical use

Chapter

Cover

pp.:  1 – 14

Foreword

pp.:  6 – 10

Editorial board

pp.:  10 – 12

List of contributors

pp.:  12 – 16

Contents

pp.:  14 – 6

Chapter 2. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering’

pp.:  42 – 58

Chapter 3. Engineering, expression, purification, and production of recombinant thermolysin

pp.:  58 – 80

Chapter 4. Preparation of recombinant vaccines

pp.:  80 – 110

Chapter 5. Advances in antibody manufacturing using mammalian cells

pp.:  110 – 130

Chapter 6. Pharming and transgenic plants

pp.:  130 – 164

Chapter 7. Porous silicon protein microarray technology and ultra-/superhydrophobic states for improved bioanalytical readout

pp.:  164 – 216

Chapter 8. Production of plasmid DNA for pharmaceutical use

pp.:  216 – 238

Chapter 9. Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents

pp.:  238 – 280

Chapter 10. Ganoderma lucidum and its pharmaceutically active compounds

pp.:  280 – 318

Chapter 11. Citric acid production

pp.:  318 – 360

Chapter 12. Using nanotechnology to improve the characteristics of antineoplastic drugs: Improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel

pp.:  360 – 374

Index of authors

pp.:  374 – 376

Keyword index

pp.:  376 – 380

The users who browse this book also browse